© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Biktarvy
FDA Approves Gilead’s Single-Tablet HIV Regimen Biktarvy
Biktarvy (bictegravir + tenofovir alafenamide + emtricitabine) 101
Chart of Approved and Experimental HIV Medications
Authentic packaging for Descovy and Biktarvy

UPDATE: Justice Department Probes Network That Allegedly Sold Fake HIV Meds

In January, Gilead Sciences claimed that over $250 million in counterfeit meds were sold and that it had sued the illegal distributors.
Descovy and Truvada

TAF Versus TDF: What’s the Difference?

POZ Poll: Have you ever come across counterfeit HIV meds?

Treatment: Biktarvy for Kids

Biktarvy is now available for small children.

2021 Top HIV News Stories

HIV disclosure, discrimination, COVID-19 and PrEP—did a single HIV news item dominate 2021 headlines?

Biktarvy Is Now An Option for Younger Children

The Food and Drug Administration approved the single-pill treatment for children weighing at least 30 pounds.

Switching to an Integrase Inhibitor Plus TAF Is Associated With Weight Gain

People who switched to such a regimen gained up to 10 pounds in nine months.

Beware of Counterfeit Versions of These Two HIV Meds

Fake tablets of Biktarvy and Descovy are being distributed at pharmacies, warns Gilead Sciences. Here’s how to spot the authentic HIV meds.

Seeing Ads for HIV Meds During the Olympics? That’s a Win For Everyone.

I love the Olympics. And I love seeing people with HIV living their best lives in between badminton and canoeing competitions.

Confirmed: For Black Americans, Biktarvy Effectively Controls HIV

Undetectable viral load improves longevity and prevents transmission of HIV.

Tivicay, Biktarvy Are Tops for Tots

There are now more once-daily treatment options for the tiniest members of the HIV community.

Updated Pediatric HIV Guidelines Nod to Tivicay for Infants

New guidelines from the Department of Health and Human Services went into effect immediately.

Bictegravir and Dolutegravir Tied to Metabolic Side Effects

These two integrase inhibitors are associated with high blood sugar and diabetes.

Switching to Biktarvy Is a Success for African Americans With HIV

Black study participants switched from a regimen with two nucleoside/nucleotide reverse transcriptase inhibitors plus one other HIV drug.

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.

Biktarvy Is Safe for Seniors

Pooled results from recent studies found a high rate of full viral suppression and no major safety concerns.
Advertisement
Science News
Features

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.